MTIP Closes Second Healthtech Growth Fund, at $250M


MTIP, a Basel, Switzerland-based healthtech focused private equity firm, closed MTIP Fund II, SCSp, at USD $250m.

New and existing investors include multiple renowned institutional investors, pension funds, family offices, hospitals, and foundations. 

The vehicle provides growth capital to entrepreneurial and fast-growing digital health and digitally-connected medical device companies. MTIP Fund II provides up to €25m in funding

Led by Dr. Christoph Kausch, Managing Partner, the investment team closely observes relevant healthcare and societal trends to source the most significant players in various markets. MTIP streamlines an exclusive flow of investment opportunities, which is enhanced by the firm’s network, its leading role in Europe, as well as its specific strategy to invest solely in healthtech companies.

The firm has already made five investments out of its second fund: Oviva, Trialbee, Koa Health, Intelligencia and Mediktor.